Spectrophotometric Method for Determination of Trimetazidine in Formulation Using Chloranil as Chromogenic Agent
More details
Hide details
Department of Chemical Engineering, Hanseo University; 360 Daegok-ri, Haemi-myun, Season - 360-706, Chungcheongnam-do, South Korea
Department of Nano Technology, Biotechnology centre, Anna University of Technology, Jothipuram,Coimbatore-641047,Tami Nadu, India
Mani Ganesh   

Department of Chemical Engineering, Hanseo University; 360 Daegok-ri, Haemi-myun, Season - 360-706, Chungcheongnam-do, South Korea
Publish date: 2017-10-14
Eurasian J Anal Chem 2011;6(1):22–30
A new, simple, selective and more reproducible spectrophotometric method for the determination of trimetazidine (TMZ), a piperizinyl antianginal has been developed and validated. This method was based on the formation of a blue colored chromogen between trimetazidine and chloranil acetaldehyde reagent in DMSO. The chromogen exhibit maximum absorbance at 627 nm with molar absorptivity of 5.205 x 104 lit mol-1 cm-1 in methanol. Beer’s law was found to be obeyed in the concentration range of 30 - 65 μg mL-1 with linear regression of 0.9984, while the percentage recovery and the limit of detection 98.81-99.91%, 5.5 μg mL-1 respectively. From the percentage recovery and placebo studies it was concluded that there was no interference of additives during the estimation. This shows the suitability of this method for the routine analysis of the trimetazidine in tablet formulation.
Reynolds J E F (1993) Martindale: The Extrapharmacopoeia. The Pharmaceutical Press, London, 33th edn., p. 1026.
Fantini E, Demaison L, Sentex E, Grynberg A, Athias P (1994) Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 26: 949.
Renaud J F (1998) Internal pH, Na+ and Ca++ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drug Ther 1:677.
Demaison L, Fantini E, Sentex E, Grynberg A, Athias P(1995)Trimetazidine:in vitro influence on heart mitochondrial function. Am J Cardiol 76: 31B.
Sentex E, Sergiel J P, Lucien A, Grynberg A (1997) Trimetazidine increases phosppholipid turnover in ventricular myocyte. Mol Cell Biochem 175(1-2) :153.
Harpey C, Clauser P, Labrid C, Freyria J L, Poirier J P (1989) Trimetazidine, A cellular anti-ischemic agent. Cardiovasc Drug Rev 6: 292.
Bari V R., Dhorda U J, Sundaresan M (1999) Trace determination of trimetazidinedine hydrochloride inhuman blood plasma. Ind Drugs 36:289.
Fay L, Michel G, Goupit P, Harpey C, Prost M (1989) Determination of trimetazidine in biological fluids by gas chromatography-mass spectrometry. J Chromatogr 490:.
Thoppil S O, Cardoza R M, Amin, P D (2001) Stability indicating HPTLC determination of Trimetazidine as bulk drug and in pharmaceutical formulations. J Pharm Biomed Anal 25:15.
Krishnamoorthy G, Ganesh M (2001) Spectrophotometric determination of trimetazidine dihydrochloride in bulk and solid dosage forms. Ind J Pharm Sci 63:.
Leonidas P P and Antony C C (2000) Analytical applications of chemiluminogenic reactions. Anal Chim Acta 413: 175.
Ghoneim M M, Khashaba P Y, Beltagi A M (2002) Determination of trimetazidine HCl by adsorptive stripping square-wave voltammetry at a glassy carbon electrode J Pharm Biomed Anal 27: 235.
Lories I, Bebawy M F, Tarras E L, Samah A, Sabour E L (2004) Determination of trimetazidine dihydrochloride in the presence of its acid-induced degradation products. J. AOAC Inter 87:827.
Ding L, Gong B, Chu X., Hu J, Zheng H (2007) Sensitive and rapid LC–ESI-MS method for the determination of trimetazidine in human plasma. J Pharm Biomed Anal 44: 526.
Shihoo C J, Suhagia B N, Rathod I S, Thakore S S (1996) Spectrophotometric estimation of piperazine in dosage forms using dichlone and acetaldhyde as reagent. Ind J Pharm Sci 58: 219.
Job P (1936) Ann. Chem. 16, 97. In Advanced Physicochemical Experiments. 2nd edition. Oliner and Boyd, Edinburgh; 1964:54.
Methodology ICH Harmonised Tripartite Guideline (Nov 2005) Validation of analytical procedures: Text and methodaloggy Q2(R1) Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on, 6 November, 1996.
The United States Pharmacopeia (2000) The National Formulary 19, US Pharmacopeial Convention Inc., Rockville, MD.
The British Pharmacopoeia (1985) Her Majesty's Stationery Office London.